NUTRITIONAL HABITS, COMPLIANCE WITH HEALTHY DIET AND INSULIN THERAPY, DEPRESSION AND FAMILY FUNCTIONALITY IN CHILDREN WITH TYPE 1 DIABETES MELLITUS DURING THE COVID-19 PANDEMIC PERIOD
Overview
Authors
Affiliations
Context: The relationship between life changes and glycemic control in children with type 1 diabetes during the pandemic period was examined.
Objective: We aimed to investigate the effect of the pandemic period on 66 children (aged 5-18 years) with type 1 diabetes using scales evaluating family functionality, nutritional habits, adherence to treatment and depression status.
Design: It is a cross-sectional clinical and laboratory study using certain scales for its descriptive features.
Subjects And Methods: Demographic characteristics, anthropometric measurements, laboratory investigations were evaluated. Family functionality of the patients were evaluated with Smilkstein's family APGAR scale, motivation and knowledge levels were evaluated with the 6-item Morisky medication adherence scale (MMAS-6), nutritional habits were evaluated with the Mediterranean diet quality index (KIDMED), and depression status was evaluated with the children depression inventory (CDI).
Results: The mean HbA level increased significantly in the first year of the pandemic compared to the onset of the pandemic period (8.5% . 8.9%, p: 0.003). In the responses to these scales, children with diabetes have high family functionality (89.4%), high motivation (90.9%) and high knowledge level about adherence to treatment (97%). Furthermore, healthy eating habits (high KIDMED index scores 92.4%), and low degree of depression score (95.5%) have been observed. We detected a statistically significant positive correlation between HbA and CDI scores (r: 0.27; p: 0.02), and a negative correlation between HbA and MMAS-6 motivation score (r: -0.30; p: 0.01).
Conclusions: In this study, the effect of motivation and mood changes on glycemic control was more clearly demonstrated.
Zhu Y, Chen R, Han H, Lin X, Shu M J Health Popul Nutr. 2025; 44(1):6.
PMID: 39780286 PMC: 11714989. DOI: 10.1186/s41043-024-00714-0.
Banariu G, Tica I, Rus M, Onuc S, Neagoe G, Tica V Acta Endocrinol (Buchar). 2024; 19(3):307-313.
PMID: 38356980 PMC: 10863967. DOI: 10.4183/aeb.2023.307.
Gafencu M, Steflea R Acta Endocrinol (Buchar). 2024; 19(3):403-406.
PMID: 38356968 PMC: 10863966. DOI: 10.4183/aeb.2023.403.
Covid 19 and diabetes in children: advances and strategies.
Wu Z, Wang J, Ullah R, Chen M, Huang K, Dong G Diabetol Metab Syndr. 2024; 16(1):28.
PMID: 38287388 PMC: 10823738. DOI: 10.1186/s13098-024-01267-2.